Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2690402, 10 pages
https://doi.org/10.1155/2017/2690402
Research Article

Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis

1Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
2Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, EPE, Lisbon Academic Medical Centre, Lisboa, Portugal
3EpiDoC Unit, CEDOC, NOVA Medical School, Universidade Nova de Lisboa, Lisboa, Portugal
4Musculoskeletal Diseases and Inflammation Research Group, Biomedicum Helsinki 1, Faculty of Medicine, Institute of Clinical Medicine, University of Helsinki, Helsinki, Finland

Correspondence should be addressed to Inês P. Perpétuo; moc.liamg@outeprep.seni

Received 1 October 2016; Accepted 4 January 2017; Published 13 February 2017

Academic Editor: Sadiq Umar

Copyright © 2017 Inês P. Perpétuo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • L. A. Knyazeva, N. Damjanov, L. I. Knyazeva, N. S. Meshcherina, and I. I. Goryainov, “Effect Of Golimumab On Immunological Markers For Bone Metabolism And On Arterial Stiffness In Patients With Rheumatoid Arthritis,” Rheumatology Science and Practice, vol. 56, no. 3, pp. 286–292, 2018. View at Publisher · View at Google Scholar
  • Syed A.A. Rizvi, Ayman M. Saleh, Sultan S. Ahmed, Rais A. Ansari, Jacqueline Bullock, Duc P. Do, and Jasmin Ahmed, “Rheumatoid arthritis: A brief overview of the treatment,” Medical Principles and Practice, vol. 27, no. 6, pp. 501–507, 2019. View at Publisher · View at Google Scholar